David Krisky

Dr. Krisky is a pathologist and virologist with 20 years of experience and is an inventor of the core technologies of the NET platform. Prior to founding PeriphaGen Dr. Krisky was the Senior Director of Medical Science and Clinical Safety for Diamyd Incorporated and was responsible for the product development and clinical program for the NET platform, the clinical safety of Phase I and Phase II NET platform clinical trials, and the clinical safety of the global Phase III clinical trials of the Diamyd Type 1 Diabetes product. Dr. Krisky leads PeriphaGen clinical development of NET products for neuropathic pain, neuropathy, and neuronal regeneration as well the clinical trial design and implementation.